跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BUPRENORFINA/NALOXONA ZENTIVA 2 MG/0,5 MG COMPRIMIDOS SUBLINGUALES EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BUPRENORFINA/NALOXONA ZENTIVA 2 MG/0,5 MG COMPRIMIDOS SUBLINGUALES EFG
Approved
STANDARD
BUPRENORFINA/NALOXONA ZENTIVA 2 MG/0,5 MG COMPRIMIDOS SUBLINGUALES EFG
Zentiva K.S.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 19, 2021
Approval ID
3385d0fa2d7cdfd6
Company
Zentiva K.S.
Type
Standard
Approval Details
Approval Id
3385d0fa2d7cdfd6
Drug Cima Aemps Name
BUPRENORFINA/NALOXONA ZENTIVA 2 MG/0,5 MG COMPRIMIDOS SUBLINGUALES EFG
Register Number
85791
Holder Company Name
Zentiva K.S.
Marketing Company Name
Zentiva Spain S.L.
Holder Company Detail Path
/organization/zentiva-k-s
Authorization Date
2021-02-19
Dosage Form
COMPRIMIDO SUBLINGUAL
Dose
2 mg/0,5 mg
Route Of Administration
VÍA SUBLINGUAL
Prescription Type
Diagnóstico Hospitalario. Psicótropos
Commercialized
No
Company Name
Zentiva K.S.
Company Detail Path
/organization/zentiva-k-s
Company Information
Pharmaceutical Company Name
Zentiva, k.s.
Country Name
Czech Republic
City Name
praha,hlavní město praha,country_cz
Address
U kabelovny 130/22
Active Ingredients
BUPRENORFINA HIDROCLORURO
2,16 mg
NALOXONA HIDROCLORURO DIHIDRATO
0,61 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 19, 2021
Approval ID
3385d0fa2d7cdfd6
Type
Standard
Back to CIMA-AEMPS Approvals